MARKET

APLM

APLM

APOLLOMICS INC
NASDAQ
18.60
+0.35
+1.92%
After Hours: 18.69 +0.09 +0.48% 16:10 11/10 EST
OPEN
18.18
PREV CLOSE
18.25
HIGH
20.11
LOW
17.80
VOLUME
10.90K
TURNOVER
--
52 WEEK HIGH
28.29
52 WEEK LOW
12.58
MARKET CAP
54.22M
P/E (TTM)
-2.4587
1D
5D
1M
3M
1Y
5Y
1D
Apollomics H1 EPS $(4.06) Up From $(11.37) YoY
Benzinga · 1d ago
Press Release: Apollomics Reports First-Half 2026 Financial Results
Dow Jones · 1d ago
Press Release: Apollomics Reports First-Half 2026 -2-
Dow Jones · 1d ago
Apollomics price target lowered to $38 from $50 at Rodman & Renshaw
TipRanks · 1d ago
Weekly Report: what happened at APLM last week (1102-1106)?
Weekly Report · 1d ago
Apollomics GAAP EPS of -$4.04
Seeking Alpha · 4d ago
Weekly Report: what happened at APLM last week (1026-1030)?
Weekly Report · 11/02 09:10
Weekly Report: what happened at APLM last week (1019-1023)?
Weekly Report · 10/26 09:10
More
About APLM
Apollomics Inc. is a clinical-stage biopharmaceutical company focusing on discovering and developing oncology therapies to address unmet medical needs, especially for difficult-to-treat and treatment-resistant cancers. The product candidates in its pipeline are categorized into two groups based on their mechanisms of action, each of which contains product candidates at different stages of development: tumor inhibitors and immuno-oncology drugs. Its tumor inhibitor product candidates consist of three small-molecule inhibitors against different uncontrolled growth signaling pathways in cancer cells: vebreltinib, APL-102 and APL-122. Its three immuno-oncology product candidates consist of APL-501, APL-502 and APL-80. Vebreltinib is a potent, oral active selective c-Met inhibitor. APL-102 is an oral active, small molecule Multiple Tyrosine Kinase Inhibitor. APL-122 is a tumor inhibitor candidate, targeting ErbB1/2/4 signaling pathways. APL-501 is an anti-PD-1 antibody product candidate.

Webull offers Apollomics Inc stock information, including NASDAQ: APLM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APLM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APLM stock methods without spending real money on the virtual paper trading platform.